Recently, I was having a conversation with a family member of mine who is currently in nursing school. She is learning about medications and let me know about something really cool that she recently learned- the medication, Mifepristone, can be used to treat Cushing's disease. This blew my mind! My only knowledge of Mifepristone is that its used for medication abortions. Typically, a regiment of two medications is administered- Mifepristone and Misoprostol (Braverman et al., 2025).
First, Mifepristone, a progesterone antagonist, will be given to the patient to be taken orally (Braverman et al., 2025). Progesterone is vital for the proper growth if a pregnancy, and a reduced amount, induced by Mifepristone, will prepare the patient's cervix to expel the pregnancy (Braverman et al., 2025). Finally, the medical provider will administer Misoprostol to the patient to be taken one of several ways: buccally, sublingually, vaginally or orally (Braverman et al., 2025). Misoprostol will help to expel the pregnancy from the patient's uterus, and can be associated with flu-like side effects (Braverman et al., 2025).
So how does this medication, usually used to terminate pregnancy, help treat Cushing's disease?! Cushing’s disease is a disorder involving the endocrine system in which there is an increase in glucocorticoids in your system (Morgan & Laufgraben, 2013). This can cause symptoms like weight gain, depression, and muscle weakness (Morgan & Laufgraben, 2013). The good news?! Mifeprestone is a glucocorticoid receptor agonist- so it blocks glucocorticoid from binding to its receptor and wreaking havoc on the body (Morgan & Laufgraben, 2013). I find it super cool that one medication can treat so many things!
References:
Braverman, M., Dayan-Schwartz, A., Ben-David, Y., Kachta, O., & Zafran, N. (2025). Early pregnancy termination with mifepristone and Misoprostol: Concurrent vs. 48-hour interval administration in a randomized controlled trial. Journal of Clinical Medicine, 14(21), 7616. https://doi.org/10.3390/jcm14217616
Morgan, F. H., & Laufgraben, M. J. (2013). Mifepristone for management of Cushing’s syndrome. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 33(3), 319–329. https://doi.org/10.1002/phar.1202
It is really wild how one medication can have a completely different use depending on the context it is in. I also only knew that Mifepristone was used for medication abortions, so learning it can be used to manage Cushing’s disease shows how versatile receptor-targeting drugs can be. The explanation of how Mifepristone works as a progesterone antagonist vs how it functions as a glucocorticoid receptor blocker has really highlighted how different pathways can be affected by the same molecule.
ReplyDeleteThough one thing I am curious about is how Mifepristone affects women who are not pregnant. Since this blocks the progesterone receptors there would be concerns about menstrual cycle changes, hormonal changes, or even if there would be fertility impacts from long term use. Would the providers need to manage more side effects than with normal Cushings? Overall your post was super cool and interesting to read. And also highlighted how medications can have multiple therapeutic roles!